美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
68462-494-30	68462-494	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20200106	N/A	ANDA	ANDA209433	Glenmark Pharmaceuticals Inc., USA	DEFERASIROX	125 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (68462-494-30)
68462-494-90	68462-494	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20200106	N/A	ANDA	ANDA209433	Glenmark Pharmaceuticals Inc., USA	DEFERASIROX	125 mg/1	90 TABLET, FOR SUSPENSION in 1 BOTTLE (68462-494-90)
68462-495-30	68462-495	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20200106	N/A	ANDA	ANDA209433	Glenmark Pharmaceuticals Inc., USA	DEFERASIROX	250 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (68462-495-30)
68462-495-90	68462-495	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20200106	N/A	ANDA	ANDA209433	Glenmark Pharmaceuticals Inc., USA	DEFERASIROX	250 mg/1	90 TABLET, FOR SUSPENSION in 1 BOTTLE (68462-495-90)
68462-496-30	68462-496	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20200106	N/A	ANDA	ANDA209433	Glenmark Pharmaceuticals Inc., USA	DEFERASIROX	500 mg/1	30 TABLET, FOR SUSPENSION in 1 BOTTLE (68462-496-30)
68462-496-90	68462-496	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, FOR SUSPENSION	ORAL	20200106	N/A	ANDA	ANDA209433	Glenmark Pharmaceuticals Inc., USA	DEFERASIROX	500 mg/1	90 TABLET, FOR SUSPENSION in 1 BOTTLE (68462-496-90)